Content Block Tag: NRG-HN010: Metastatic HER2-Expressing Salivary Gland Cancer
‘Text/HTML’ of page ‘NRG-HN010: Metastatic HER2-Expressing Salivary Gland Cancer’
Am I eligible for this study? If you over the age of 18 with HER2-expressing salivary gland cancer that has come back, spread outside of your salivary gland, or cannot be removed by surgery, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer […]
Read More
‘Text/HTML’ of page ‘NRG-HN010: Metastatic HER2-Expressing Salivary Gland Cancer’
About This Study NRG-HN010 is a clinical study for people with salivary gland cancer (SGC) that has the protein HER2 at high levels (“HER2-positive”) or low levels (“HER2-low”), and who have had their cancer come back (recurrent), their cancer has spread outside of the salivary gland (metastatic), or are unable to have the cancer […]
Read More